Fineman; Mark S.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Fineman; Mark S..The latest application filed is for "biguanide compositions and methods of treating metabolic disorders".

Company Profile

9.22.27

Fineman; Mark S. - San Diego CA
Fineman; Mark S. - Solana Beach CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Biguanide Compositions And Methods Of Treating Metabolic Disorders App 20220151957 - Baron; Alain D. ; et al.	2022-05-19
Biguanide compositions and methods of treating metabolic disorders Grant 11,065,215 - Baron , et al. July 20, 2	2021-07-20
Biguanide compositions and methods of treating metabolic disorders Grant 10,668,031 - Baron , et al.	2020-06-02
Biguanide Compositions and Methods of Treating Metabolic Disorders App 20200138751 - BARON; Alain D. ; et al.	2020-05-07
Chemosensory receptor ligand-based therapies Grant 10,610,500 - Baron , et al.	2020-04-07
Compositions and methods for treating metabolic disorders Grant 10,603,291 - Baron , et al.	2020-03-31
Compositions And Methods For Treating Metabolic Disorders App 20200093750 - Baron; Alain D. ; et al.	2020-03-26
Compositions And Methods For Treating Metabolic Disorders App 20190307708 - BARON; Alain D. ; et al.	2019-10-10
Biguanide Compositions and Methods of Treating Metabolic Disorders App 20190076380 - BARON; Alain D. ; et al.	2019-03-14
Compositions and methods for treating metabolic disorders Grant 10,201,511 - Baron , et al. Feb	2019-02-12
Chemosensory Receptor Ligand-Based Therapies App 20190038576 - BARON; Alain D. ; et al.	2019-02-07
Compositions comprising statins, biguanides and further agents for reducing cardiometabolic risk Grant 10,159,658 - Baron , et al. Dec	2018-12-25
Biguanide compositions and methods of treating metabolic disorders Grant 10,154,972 - Baron , et al. Dec	2018-12-18
Biguanide compositions and methods of treating metabolic disorders Grant 10,028,923 - Baron , et al. July 24, 2	2018-07-24
Chemosensory receptor ligand-based therapies Grant 9,962,344 - Baron , et al. May 8, 2	2018-05-08
Compositions and Methods for Treating Metabolic Disorders App 20180008561 - BARON; Alain D. ; et al.	2018-01-11
Compositions and methods for treating metabolic disorders Grant 9,770,422 - Baron , et al. September 26, 2	2017-09-26
Biguanide Compositions and Methods of Treating Metabolic Disorders App 20170209394 - BARON; Alain D. ; et al.	2017-07-27
Biguanide Compositions and Methods of Treating Metabolic Disorders App 20170202790 - BARON; Alain D. ; et al.	2017-07-20
Compositions Comprising Statins, Biguanides and Further Agents for Reducing Cardiometabolic Risk App 20170165209 - BARON; Alain D. ; et al.	2017-06-15
Compositions comprising statins, biguanides and further agents for reducing cardiometabolic risk Grant 9,572,784 - Baron , et al. February 21, 2	2017-02-21
Chemosensory Receptor Ligand-Based Therapies App 20170020829 - BARON; Alain D. ; et al.	2017-01-26
Chemosensory receptor ligand-based therapies Grant 9,486,463 - Baron , et al. November 8, 2	2016-11-08
Biguanide compositions and methods of treating metabolic disorders Grant 9,480,663 - Baron , et al. November 1, 2	2016-11-01
Biguanide compositions and methods of treating metabolic disorders Grant 9,481,642 - Baron , et al. November 1, 2	2016-11-01
Chemosensory receptor ligand-based therapies Grant 9,463,170 - Baron , et al. October 11, 2	2016-10-11
Compositions and Methods for Treating Metabolic Disorders App 20160095828 - BARON; Alain D. ; et al.	2016-04-07
Compositions and methods of treating metabolic disorders Grant 9,211,263 - Baron , et al. December 15, 2	2015-12-15
Chemosensory Receptor Ligand-Based Therapies App 20150265555 - BARON; Alain D. ; et al.	2015-09-24
Compositions Comprising Statins, Biguanides and Further Agents for Reducing Cardiometabolic Risk App 20150196509 - Baron; Alain D. ; et al.	2015-07-16
Chemosensory receptor ligand-based therapies Grant 9,050,292 - Baron , et al. June 9, 2	2015-06-09
Compositions and Methods for Treating Metabolic Disorders App 20150065578 - Baron; Alain D. ; et al.	2015-03-05
Biguanide Compositions and Methods of Treating Metabolic Disorders App 20150064223 - Baron; Alain D. ; et al.	2015-03-05
Biguanide Compositions and Methods of Treating Metabolic Disorders App 20140341986 - Baron; Alain D. ; et al.	2014-11-20
Biguanide compositions and methods of treating metabolic disorders Grant 8,796,338 - Baron , et al. August 5, 2	2014-08-05
Compositions and Methods for Treating Metabolic Disorders App 20140193498 - BARON; Alain D. ; et al.	2014-07-10
Chemosensory Receptor Ligand-Based Therapies App 20140030332 - Baron; Alain D. ; et al.	2014-01-30
Compositions and Methods of Treating Metabolic Disorders App 20130177604 - Baron; Alain D. ; et al.	2013-07-11
Biguanide Compositions and Methods of Treating Metabolic Disorders App 20130095140 - Baron; Alain D. ; et al.	2013-04-18
Chemosensory Receptor Ligand-Based Therapies App 20120177730 - BARON; Alain D. ; et al.	2012-07-12
Chemosensory Receptor Ligand-Based Therapies App 20120094942 - BARON; Alain D. ; et al.	2012-04-19

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.